• Something wrong with this record ?

A Clinicopathological Study of 29 Spitzoid Melanocytic Lesions With ALK Fusions, Including Novel Fusion Variants, Accompanied by Fluorescence In Situ Hybridization Analysis for Chromosomal Copy Number Changes, and Both TERT Promoter and Next-Generation Sequencing Mutation Analysis

L. Kastnerova, P. Martinek, P. Grossmann, P. Steiner, T. Vanecek, J. Kyclova, I. Ferak, R. Zalud, O. Slehobr, P. Svajdler, M. Sulc, M. Bradamante, M. Banik, L. Hadravsky, E. Sticova, V. Hajkova, N. Ptakova, M. Michal, DV. Kazakov

. 2020 ; 42 (8) : 578-592. [pub] -

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc21020278

ALK-fused spitzoid neoplasms represent a distinctive group of melanocytic lesions. To date, few studies addressed genetic and chromosomal alterations in these lesions beyond the ALK rearrangements. Our objective was to study genetic alterations, including ALK gene fusions, telomerase reverse transcriptase promoter (TERT-p) mutations, chromosomal copy number changes, and mutations in other genes. We investigated 29 cases of Spitz lesions (11 Spitz nevi and 18 atypical Spitz tumors), all of which were ALK immunopositive. There were 16 female and 13 male patients, with age ranging from 1 to 43 years (mean, 18.4 years). The most common location was the lower extremity. Microscopically, all neoplasms were polypoid or dome shaped with a plexiform, predominantly dermally located proliferation of fusiform to spindled melanocytes with mild to moderate pleomorphism. The break-apart test for ALK was positive in 17 of 19 studied cases. ALK fusions were detected in 23 of 26 analyzable cases by Archer FusionPlex Solid Tumor Kit. In addition to the previously described rearrangements, 3 novel fusions, namely, KANK1-ALK, MYO5A-ALK, and EEF2-ALK, were found. Fluorescence in situ hybridization for copy number changes yielded one case with the loss of RREB1 among 21 studied cases. TERT-p hotspot mutation was found in 1 of 23 lesions. The mutation analysis of 271 cancer-related genes using Human Comprehensive Cancer Panel was performed in 4 cases and identified in each case mutations in several genes with unknown significance, except for a pathogenic variant in the BLM gene. Our study confirms that most ALK fusion spitzoid neoplasms can be classified as atypical Spitz tumors, which occurs in young patients with acral predilection and extends the spectrum of ALK fusions in spitzoid lesions, including 3 hitherto unreported fusions. TERT-p mutations and chromosomal copy number changes involving 6p25 (RRB1), 11q13 (CCND1), 6p23 (MYB), 9p21 (CDKN2A), and 8q24 (MYC) are rare in these lesions. The significance of mutation in other genes remains unknown.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020278
003      
CZ-PrNML
005      
20210830101910.0
007      
ta
008      
210728s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/DAD.0000000000001632 $2 doi
035    __
$a (PubMed)32701692
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kastnerova, Liubov $u Sikl's Department of Pathology, Medical Faculty in Pilsen, Charles University in Prague, Pilsen, Czech Republic $u Bioptical Laboratory, Pilsen, Czech Republic
245    12
$a A Clinicopathological Study of 29 Spitzoid Melanocytic Lesions With ALK Fusions, Including Novel Fusion Variants, Accompanied by Fluorescence In Situ Hybridization Analysis for Chromosomal Copy Number Changes, and Both TERT Promoter and Next-Generation Sequencing Mutation Analysis / $c L. Kastnerova, P. Martinek, P. Grossmann, P. Steiner, T. Vanecek, J. Kyclova, I. Ferak, R. Zalud, O. Slehobr, P. Svajdler, M. Sulc, M. Bradamante, M. Banik, L. Hadravsky, E. Sticova, V. Hajkova, N. Ptakova, M. Michal, DV. Kazakov
520    9_
$a ALK-fused spitzoid neoplasms represent a distinctive group of melanocytic lesions. To date, few studies addressed genetic and chromosomal alterations in these lesions beyond the ALK rearrangements. Our objective was to study genetic alterations, including ALK gene fusions, telomerase reverse transcriptase promoter (TERT-p) mutations, chromosomal copy number changes, and mutations in other genes. We investigated 29 cases of Spitz lesions (11 Spitz nevi and 18 atypical Spitz tumors), all of which were ALK immunopositive. There were 16 female and 13 male patients, with age ranging from 1 to 43 years (mean, 18.4 years). The most common location was the lower extremity. Microscopically, all neoplasms were polypoid or dome shaped with a plexiform, predominantly dermally located proliferation of fusiform to spindled melanocytes with mild to moderate pleomorphism. The break-apart test for ALK was positive in 17 of 19 studied cases. ALK fusions were detected in 23 of 26 analyzable cases by Archer FusionPlex Solid Tumor Kit. In addition to the previously described rearrangements, 3 novel fusions, namely, KANK1-ALK, MYO5A-ALK, and EEF2-ALK, were found. Fluorescence in situ hybridization for copy number changes yielded one case with the loss of RREB1 among 21 studied cases. TERT-p hotspot mutation was found in 1 of 23 lesions. The mutation analysis of 271 cancer-related genes using Human Comprehensive Cancer Panel was performed in 4 cases and identified in each case mutations in several genes with unknown significance, except for a pathogenic variant in the BLM gene. Our study confirms that most ALK fusion spitzoid neoplasms can be classified as atypical Spitz tumors, which occurs in young patients with acral predilection and extends the spectrum of ALK fusions in spitzoid lesions, including 3 hitherto unreported fusions. TERT-p mutations and chromosomal copy number changes involving 6p25 (RRB1), 11q13 (CCND1), 6p23 (MYB), 9p21 (CDKN2A), and 8q24 (MYC) are rare in these lesions. The significance of mutation in other genes remains unknown.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a anaplastická lymfomová kináza $x genetika $7 D000077548
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a variabilita počtu kopií segmentů DNA $7 D056915
650    _2
$a mutační analýza DNA $x metody $7 D004252
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a vysoce účinné nukleotidové sekvenování $7 D059014
650    _2
$a lidé $7 D006801
650    _2
$a hybridizace in situ fluorescenční $7 D017404
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mutace $7 D009154
650    _2
$a epiteloidní a vřetenobuněčný névus $x genetika $x patologie $7 D018332
650    _2
$a onkogenní fúze $x genetika $7 D050596
650    _2
$a fúzní onkogenní proteiny $x genetika $7 D015514
650    _2
$a promotorové oblasti (genetika) $x genetika $7 D011401
650    _2
$a sekvenční analýza DNA $7 D017422
650    _2
$a nádory kůže $x genetika $x patologie $7 D012878
650    _2
$a telomerasa $x genetika $7 D019098
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Martinek, Petr $u Sikl's Department of Pathology, Medical Faculty in Pilsen, Charles University in Prague, Pilsen, Czech Republic $u Bioptical Laboratory, Pilsen, Czech Republic
700    1_
$a Grossmann, Petr $u Sikl's Department of Pathology, Medical Faculty in Pilsen, Charles University in Prague, Pilsen, Czech Republic $u Bioptical Laboratory, Pilsen, Czech Republic
700    1_
$a Steiner, Petr $u Sikl's Department of Pathology, Medical Faculty in Pilsen, Charles University in Prague, Pilsen, Czech Republic $u Bioptical Laboratory, Pilsen, Czech Republic
700    1_
$a Vanecek, Tomas $u Sikl's Department of Pathology, Medical Faculty in Pilsen, Charles University in Prague, Pilsen, Czech Republic $u Bioptical Laboratory, Pilsen, Czech Republic
700    1_
$a Kyclova, Jitka $u Department of Pathology, University Hospital, Brno, Czech Republic
700    1_
$a Ferak, Ivan $u Agel Laboratory, Novy Jicin, Czech Republic
700    1_
$a Zalud, Radim $u Department of Pathology, Regional Hospital, Kolin, Czech Republic
700    1_
$a Slehobr, Ondrej $u Department of Pathology, Regional Hospital, Kolin, Czech Republic
700    1_
$a Svajdler, Peter $u Department of Pathology, L. Pausteur University Hospital, Kosice, Czech Republic
700    1_
$a Sulc, Miroslav $u Pathology Laboratory Chomutov, Chomutov, Czech Republic
700    1_
$a Bradamante, Mirna $u Department of Dermatology, University Hospital, Zagreb, Croatia
700    1_
$a Banik, Martin $u Department of Pathology, Regional Hospital, Karlovy Vary, Czech Republic
700    1_
$a Hadravsky, Ladislav $u Department of Pathology, 1st Faculty of Medicine and General University Hospital, Charles University in Prague, Czech Republic; and
700    1_
$a Sticova, Eva $u Clinical and Transplant Pathology Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Hajkova, Veronika $u Bioptical Laboratory, Pilsen, Czech Republic
700    1_
$a Ptakova, Nikola $u Bioptical Laboratory, Pilsen, Czech Republic
700    1_
$a Michal, Michal $u Sikl's Department of Pathology, Medical Faculty in Pilsen, Charles University in Prague, Pilsen, Czech Republic $u Bioptical Laboratory, Pilsen, Czech Republic
700    1_
$a Kazakov, Dmitry V $u Sikl's Department of Pathology, Medical Faculty in Pilsen, Charles University in Prague, Pilsen, Czech Republic $u Bioptical Laboratory, Pilsen, Czech Republic
773    0_
$w MED00000240 $t The American Journal of dermatopathology $x 1533-0311 $g Roč. 42, č. 8 (2020), s. 578-592
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32701692 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830101910 $b ABA008
999    __
$a ok $b bmc $g 1690957 $s 1140724
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 42 $c 8 $d 578-592 $e - $i 1533-0311 $m The American journal of dermatopathology $n Am J Dermatopathol $x MED00000240
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Archiving options